<DOC>
	<DOCNO>NCT02843334</DOCNO>
	<brief_summary>Fabry Disease ( FD ) rare genetic lysosomal storage disease include X-linked mutation characterize alpha-galactosidase A ( GLA ) deficiency . It cause globotriaosylceramide ( GB3 ) accumulation within blood vessel , tissue organ . This accumulation lead multisystemic deficiency , progressive kidney insufficiency . Due low prevalence non-specific symptom , FD under-diagnosed . Its estimated incidence range 1/40,000 1/120,000 live birth . A review international literature suggest high prevalence among dialysis patient . Its diagnosis could lead enzyme replacement therapy , order avoid occurrence aggravation organs irreversible lesion , enhance familial screening . We aim conduct multicentric cross-sectional prevalence study 5 area ( Rh√¥ne-Alpes-Auvergne , Ile de France , Aquitaine , Picardie department Gard ) , involve biologic collection genetic diagnosis test . Our objective measure prevalence FD among dialysis patient . Eligible patient include sign inform consent . In five participate area , dialysis center ask involvement . Nominative data French renal epidemiology information network ( REIN ) registry enable first patient screen eligibility among prevalent dialysis patient . If need ( insufficient absent data REIN registry ) , data complete medical file . A blood drop collect hemodialysis session ( monthly test peritoneal dialysis treat patient ) deposit anonymized blotting paper . For diagnosis FD , men measure alpha-galactosidase activity , whereas screen woman establish association alpha-galactosidase activity lyso-GB3 analysis . If result compatible FD , genetic mutation search order confirm diagnosis woman , , , offer familial testing . Results transmit nephrologist within next 2 9 week . Patients diagnose FD manage accordance guideline French National Authority Health ( F.N.A.H . ) .</brief_summary>
	<brief_title>Study Prevalence Fabry Disease French Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>Woman men Age 18 70 year Patient undergoing chronic renal dialysis confirm diagnosis FD diagnosis nephropathy accord French renal epidemiology information network ( REIN ) registry classification : Primitive glomerulonephritis Hypertension Diabetic nephropathy non type 1 diabetes Vascular nephropathy Pyelonephritis Unknown Informed consent sign IgA nephropathy confirm renal biopsy Diabetic nephropathy type 1 diabetes Autosomal dominant polycystic kidney disease Lawprotected patient Patient n't belong national social security system , similar system Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Fabry disease</keyword>
	<keyword>End Stage Renal Disease</keyword>
	<keyword>chronic dialysis</keyword>
	<keyword>alpha galactosidase A</keyword>
	<keyword>Lyso-GB3</keyword>
	<keyword>GLA mutation</keyword>
	<keyword>Prevalence</keyword>
</DOC>